Metraipolis › archive › dc_3744946bca95

Synergistic therapeutic impact of dichloroacetate nanoparticles and doxorubicin in modulating pyruvate dehydrogenase kinase in breast carcinoma model — Europe PMC PMID:41577989

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41577989
DOI
10.1038/s41598-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-06T13:32:26.620Z
SHA-256 of the archived text
e4da83d0741af2b096cf379f8fc5af979dac3ca8ed086a2f4127616c62637844
Stable URL of this page
https://metraipolis.com/documento/dc_3744946bca95

How to cite

Synergistic therapeutic impact of dichloroacetate nanoparticles and doxorubicin in modulating pyruvate dehydrogenase kinase in breast carcinoma model — Europe PMC PMID:41577989 — Europe PMC (en), https://europepmc.org/article/MED/41577989 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3744946bca95 (Metraipolis archive dc_3744946bca95, sha256 e4da83d0741af2b096cf379f8fc5af979dac3ca8ed086a2f4127616c62637844)
BibTeX
@misc{dc3744946bca95,
  title = {Synergistic therapeutic impact of dichloroacetate nanoparticles and doxorubicin in modulating pyruvate dehydrogenase kinase in breast carcinoma model — Europe PMC PMID:41577989},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41577989},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3744946bca95; sha256 e4da83d0741af2b096cf379f8fc5af979dac3ca8ed086a2f4127616c62637844},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41577989. Agents can read the archived copy with the MCP tool read_document.